Review ArticleContinuing Education
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
Lisa Bodei, Valentina Ambrosini, Ken Herrmann and Irvin Modlin
Journal of Nuclear Medicine November 2017, 58 (11) 1718-1726; DOI: https://doi.org/10.2967/jnumed.116.186361
Lisa Bodei
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Valentina Ambrosini
2Nuclear Medicine, Department of Experimental Diagnostic and Specialized Medicine, University of Bologna and S. Orsola-Malpighi Hospital, Bologna, Italy
Ken Herrmann
3Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
4Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany; and
Irvin Modlin
5Yale University School of Medicine, Department of Surgery, New Haven, Connecticut
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 11
November 1, 2017
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
Lisa Bodei, Valentina Ambrosini, Ken Herrmann, Irvin Modlin
Journal of Nuclear Medicine Nov 2017, 58 (11) 1718-1726; DOI: 10.2967/jnumed.116.186361
Jump to section
Related Articles
Cited By...
- Imaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma
- Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
- The Future of Nuclear Medicine as an Independent Specialty
- SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
- Aetna and 68Ga-DOTATATE: A Sequel to "The Injustice of Being Judged by the Errors of Others" (1)